Shopping Cart

Remove All

Your shopping cart is currently empty

Berberine ursodeoxycholate

Select Batch

Purity:100%

Resource Download

COA HNMR LCMS HPLC

Berberine ursodeoxycholate

Catalog No. T67974Cas No. 1868138-66-2

Berberine ursodeoxycholate (HTD1801) is an orally effective hypolipidemic agent, an ionic salt of Berberine and Ursodeoxycholic acid.Berberine ursodeoxycholate has a wide range of metabolic activity and significantly reduces liver fat content. Berberine ursodeoxycholate has been used in studies of hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability
1 mg	$32	In Stock
2 mg	$45	In Stock
5 mg	$73	In Stock
10 mg	$118	In Stock
25 mg	$237	In Stock
50 mg	$378	In Stock
100 mg	$569	In Stock
500 mg	$1,190	In Stock

Bulk & Custom

Add to Cart

Questions

Related Compound Libraries of "Berberine ursodeoxycholate"

Product Introduction

Bioactivity

Description	Berberine ursodeoxycholate (HTD1801) is an orally effective hypolipidemic agent, an ionic salt of Berberine and Ursodeoxycholic acid.Berberine ursodeoxycholate has a wide range of metabolic activity and significantly reduces liver fat content. Berberine ursodeoxycholate has been used in studies of hyperlipidemia, non-alcoholic steatohepatitis (NASH) and diabetes.
In vivo	Berberine ursodeoxycholate (BUDCA) tested in this phase 2 study (1000 mg twice a day) results in a significant reduction in liver fat content after 18 weeks of treatment. This improvement in liver fat content is associated with improvement in glycemic control, the apparent improvement in hepatic inflammation and injury with reductions in serum levels of liver associated enzymes, significant weight loss, and modest reductions in serum lipid levels.[1]
Alias	HTD1801, BUDCA

Chemical Properties

Molecular Weight	217.69
Formula	C6H8CuN3O2
Cas No.	1868138-66-2

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 50 mg/mL (229.68 mM)

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	4.5937 mL	22.9684 mL	45.9369 mL	229.6844 mL
5 mM	0.9187 mL	4.5937 mL	9.1874 mL	45.9369 mL
10 mM	0.4594 mL	2.2968 mL	4.5937 mL	22.9684 mL
20 mM	0.2297 mL	1.1484 mL	2.2968 mL	11.4842 mL
50 mM	0.0919 mL	0.4594 mL	0.9187 mL	4.5937 mL
100 mM	0.0459 mL	0.2297 mL	0.4594 mL	2.2968 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc